What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Gene
- Disease
André C. Knulst mainly investigates Immunology, Food allergy, Immunoglobulin E, Allergy and Allergen.
His Immunology research is multidisciplinary, incorporating elements of Quality and Pollen.
His Food allergy study incorporates themes from Prevalence, El Niño, Pediatrics and House dust mite.
His studies deal with areas such as Dermatology, Diagnostic accuracy, Quality assessment, Meta-analysis and Positive test result as well as Immunoglobulin E.
His Allergy research includes elements of Environmental health, Provocation test, Position paper and Desensitization.
André C. Knulst interconnects Cross-reactivity and Milk allergy in the investigation of issues within Allergen.
His most cited work include:
- Standardization of food challenges in patients with immediate reactions to foods--position paper from the European Academy of Allergology and Clinical Immunology. (547 citations)
- Apple allergy across Europe: how allergen sensitization profiles determine the clinical expression of allergies to plant foods. (265 citations)
- Ara h 8, a Bet v 1-homologous allergen from peanut, is a major allergen in patients with combined birch pollen and peanut allergy. (248 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Food allergy, Allergy, Immunology, Immunoglobulin E and Allergen.
His Food allergy study also includes
- Pediatrics which is related to area like Outpatient clinic,
- Internal medicine together with Gastroenterology and Placebo.
His research investigates the connection between Allergy and topics such as Sensitization that intersect with issues in Storage protein and Atopic dermatitis.
He regularly ties together related areas like Provocation test in his Immunology studies.
His Immunoglobulin E research is multidisciplinary, relying on both Epitope, Molecular biology, Recombinant DNA and Microbiology.
André C. Knulst has researched Allergen in several fields, including Cross-reactivity, Biochemistry and Pollen, Botany.
He most often published in these fields:
- Food allergy (43.33%)
- Allergy (40.83%)
- Immunology (35.42%)
What were the highlights of his more recent work (between 2018-2021)?
- Food allergy (43.33%)
- Allergy (40.83%)
- Omalizumab (6.25%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Food allergy, Allergy, Omalizumab, Immunoglobulin E and Internal medicine.
The various areas that he examines in his Food allergy study include Odds ratio, Logistic regression, Biochemistry, Clinical history and Screening questionnaire.
His Allergy study contributes to a more complete understanding of Immunology.
His study on Omalizumab also encompasses disciplines like
- MEDLINE most often made with reference to Dermatology,
- Chronic urticaria, which have a strong connection to Drug survival, Cohort and Pediatrics,
- Angioedema which intersects with area such as Bradykinin.
His Immunoglobulin E study integrates concerns from other disciplines, such as Epitope, Molecular biology and Sensitization.
As part of one scientific family, André C. Knulst deals mainly with the area of Internal medicine, narrowing it down to issues related to the Gastroenterology, and often Hereditary angioedema, Tryptase and Outpatient clinic.
Between 2018 and 2021, his most popular works were:
- Birch pollen allergy in Europe (50 citations)
- Food Allergy in Adults: Substantial Variation in Prevalence and Causative Foods Across Europe. (27 citations)
- Chemically modified peanut extract shows increased safety while maintaining immunogenicity. (21 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Gene
Food allergy, Allergy, Omalizumab, Immunology and Environmental health are his primary areas of study.
His Food allergy study incorporates themes from Serology, Internal medicine, Physical exercise, Asthma and Screening questionnaire.
His biological study spans a wide range of topics, including Pollen, Epitope, B-Cell Epitopes, Disease status and Immunoglobulin E.
In his study, MEDLINE, Incidence and Refractory is strongly linked to Dermatology, which falls under the umbrella field of Omalizumab.
His work on Immune reactivity as part of general Immunology research is frequently linked to Diagnostic tools, thereby connecting diverse disciplines of science.
His study in Environmental health is interdisciplinary in nature, drawing from both Adult population and Skin symptoms.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
